Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

BACKGROUND: The severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is extremely variable, ranging from asymptomatic patients to those who develop severe acute respiratory distress syndrome (ARDS). As for now, there are still no really effective therapies for coronavir...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzella, Francesco, Fontana, Matteo, Salvarani, Carlo, Massari, Marco, Ruggiero, Patrizia, Scelfo, Chiara, Barbieri, Chiara, Castagnetti, Claudia, Catellani, Chiara, Gibellini, Giorgia, Falco, Francesco, Ghidoni, Giulia, Livrieri, Francesco, Montanari, Gloria, Casalini, Eleonora, Piro, Roberto, Mancuso, Pamela, Ghidorsi, Luca, Facciolongo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523258/
https://www.ncbi.nlm.nih.gov/pubmed/32993751
http://dx.doi.org/10.1186/s13054-020-03306-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523258/
https://www.ncbi.nlm.nih.gov/pubmed/32993751
http://dx.doi.org/10.1186/s13054-020-03306-6

Ejemplares similares